I've had a version of the same conversation with scientists at almost every large pharma I've worked with. The CRO sent the file. The file arrived. And then a biologist with fifteen years of experience spent the next two days parsing columns in Excel, chasing a missing compound ID over email, and writing up a QC deviation by hand that no one would ever be able to find again.
The file receipt problem is solved. The data usability problem is not. At a typical large pharma, scientists spend 10,000 to 32,000 hours a year reviewing CRO data — not because anyone wants them to, but because there's no other way. Some analysts spend more than half their time on it. The decisions they make during that review are neither searchable nor traceable. When a data integrity finding turns up at FDA submission, it can push a program 12 to 24 months. The aggregate cost of this — in labor, rework, and delayed IND readiness — runs to more than $10 million a year for a top-25 pharma.
We built CRO Connect inside Tetra OS's Scientific Use Case Factory because the problem is a workflow problem, not a storage problem. Two applications work together. The CRO Onboarding Assistant lets a scientist describe a new CRO's file format in plain English — the agent reads the file, maps it to a common data schema, writes the parsing pipeline, and generates QC validation rules from a natural language prompt. What used to take a data engineer 10 to 20 hours per workstream now takes a scientist under an hour.
The CRO Data Review app is where those rules go to work. Every file that arrives in Tetra OS is parsed and checked automatically. Flagged values surface with plain-language explanations. A scientist can reject an entire batch with one action; the CRO gets an automated email with the reviewer's annotations attached. One of our customers recovered 10 to 20% of their IND preparation timeline — one to two months — by closing this loop.
The return on this is 2.7x to 10.5x on a per-division basis. But the number that matters most to the scientists I talk to is simpler: review time drops 80%. That's two to three hours per batch down to twenty minutes. That's the afternoon back.
By end of year, the system will start learning from reviewer behavior — inferring validation rules from prior workstreams, so the second CRO of a given assay type takes a fraction of the time to onboard as the first. The long-term vision is a single interface from data request through QC sign-off, with the platform accumulating intelligence on CRO quality patterns over time. As your outsourcing volume grows, the review cost doesn't grow with it.
Watch the full demo here. If you want to go deeper, join us at office hours — or request a demo and we'll walk through it with your data in mind.